ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,142, issued on Aug. 5, was assigned to TRANSGENE (Illkirch Graffenstaden, France).
"Recombinant pseudocowpoxvirus" was invented by Karola Rittner (Strasbourg, France), Christelle Remy (Lochwiller, France) and Christine Thioudellet (Strasbourg, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is in the field of viral immunotherapy. The invention provides new pseudocowpox (PCPV) viruses, in particular recombinant PCPV, composition thereof as well as their therapeutic use for preventing or treating diseases, and, notably, proliferative diseases like cancers and restenosis and infectious diseases such as chronic ones. The prese...